# Study for the Prevention of Oral Mucositis (SPOM)

> **NCT05338398** · PHASE1,PHASE2 · UNKNOWN · sponsor: **E2Bio Life Sciences, LLC** · enrollment: 100 (estimated)

## Conditions studied

- Oral Mucositis

## Interventions

- **DEVICE:** Bocaliner
- **DRUG:** Benzydamine

## Key facts

- **NCT ID:** NCT05338398
- **Lead sponsor:** E2Bio Life Sciences, LLC
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2022-04-15
- **Primary completion:** 2023-10-30
- **Final completion:** 2023-12-31
- **Target enrollment:** 100 (ESTIMATED)
- **Last updated:** 2023-09-08

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05338398

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05338398, "Study for the Prevention of Oral Mucositis (SPOM)". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT05338398. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*